Northwestern Mutual Wealth Management CO Bei Gene, Ltd. Transaction History
Northwestern Mutual Wealth Management CO
- $147 Billion
- Q3 2025
A detailed history of Northwestern Mutual Wealth Management CO transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 24 shares of BGNE stock, worth $5,441. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24
Previous 29
17.24%
Holding current value
$5,441
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BGNE
# of Institutions
297Shares Held
30.4MCall Options Held
147KPut Options Held
195K-
Baker Bros. Advisors LP New York, NY8.8MShares$1.99 Billion16.25% of portfolio
-
Primecap Management CO Pasadena, CA5.08MShares$1.15 Billion0.91% of portfolio
-
Capital International Investors Los Angeles, CA5.05MShares$1.14 Billion0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.63MShares$370 Million0.06% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E91.03MShares$234 Million7.05% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...